Recombinant Human HAGHL Protein，GST

HAGHL (Hydroxyacyl-glutathione hydrolase) is an enzyme that plays a crucial role in the detoxification of aldehydes and harmful metabolites in the human body. The enzyme is part of the glutathione S-transferase family and is involved in the hydrolysis of hydroxyacyl-glutathione conjugates, which are formed during metabolic processes. Research into HAGHL has gained significance due to its potential implications in various diseases, especially those related to oxidative stress and inflammation. Elevated levels of harmful metabolites associated with metabolic disorders can lead to tissue damage and contribute to conditions such as cancer, neurodegenerative diseases, and cardiovascular disorders. Understanding the structure and function of HAGHL at the molecular level can provide insights into its enzymatic activity and regulatory mechanisms. Furthermore, the synthesis and characterization of recombinant HAGHL proteins facilitate studies on enzyme kinetics, substrate specificity, and potential therapeutic applications. The exploration of HAGHL's role in cellular detoxification pathways not only aids in elucidating disease mechanisms but also identifies novel biomarkers for disease diagnosis and prognosis. As research progresses, HAGHL emerges as a promising target for drug development, with the potential to enhance detoxification strategies and mitigate the adverse effects of toxic metabolites in various pathological conditions.